A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/14 (2006.01) A61P 31/04 (2006.01) C07K 9/00 (2006.01)
Patent
CA 2301589
The present invention is directed to methods for treating infections caused by <u>Staphylococcus aureus</u> with reduced glycopeptide sensitivity. The invention is preferably practiced with strains of <u>Staphylococcus aureus</u> which are methicillin resistant, such as the Mu50 strain.
La présente invention concerne des méthodes de traitement d'infections provoquées par un staphylocoque doré présentant une sensibilité réduite aux glycopeptides. L'invention s'utilise, de préférence, avec des souches de staphylocoque doré qui sont résistantes à la méthicilline, comme la couche Mu50.
Nicas Thalia Ioanna
Preston David Albert
Zeckel Michael Lee
Eli Lilly And Company
Fasken Martineau Dumoulin Llp
LandOfFree
Therapy for staphylococcus aureus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapy for staphylococcus aureus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapy for staphylococcus aureus will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1914452